Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
60,893,283
-
Total 13F shares
-
29,653,795
-
Share change
-
+20,944,744
-
Total reported value
-
$42,404,231
-
Price per share
-
$1.43
-
Number of holders
-
40
-
Value change
-
+$30,732,112
-
Number of buys
-
28
-
Number of sells
-
14
Institutional Holders of Equillium, Inc. - Common Stock (EQ) as of Q3 2025
As of 30 Sep 2025,
Equillium, Inc. - Common Stock (EQ) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,653,795 shares.
The largest 10 holders included
ADAR1 Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Decheng Capital LLC, Woodline Partners LP, Balyasny Asset Management L.P., STEMPOINT CAPITAL LP, TAKEDA PHARMACEUTICAL CO LTD, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, and CANTOR FITZGERALD, L. P..
This page lists
40
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.